ACC 2009 schedule

Here is the page we will use to coordinate interviews at ACC 2009

Filming location: Rosen Plaza Hotel 9700 International Drive Phone: 407-996-9700

Filming will occur from Saturday to Tuesday (March 28 - March 31). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. As a presenter, you should go ahead and speak about your topic/present your slides.

---

Click on Date for Detailed Schedule

Saturday March 28, 2009

Sunday March 29, 2009

Monday March 30, 2009

Tuesday March 31, 2009

---

Saturday, March 28, 2009

Presentations will occur throughout the day on Saturday. Dr. Gibson will not be available to interview between 2:00 and 5:00 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

2:00 PM

• Interviewee: Gilles Montalescot (Slide presentation)
• Confirmed (Y/N): Y
• Trial: Immediate Versus Next Day Catheterization in Non-ST Elevation Acute Coronary Syndrome: Results of the Multicenter Randomized ABOARD Study
• Phone number: +33 6 12592326

5:00 PM

Return to top

Sunday March 29, 2009

Presentations will occur throughout the day on Sunday. Dr. Gibson will not be available to interview between 7:00 AM and 11:00 AM, 1:30 PM to 4:00 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

10:30 AM

• Interviewee: Ziyad M. Hijazi, M.D., MPH, FSCAI
• Confirmed: Y
• Topic: SCAI's Structural Heart Disease Council and other SCAI initiatives
• On-site phone: 773-936-8481

11:00 AM

• Interviewee: Bonnie H. Weiner, M.D., FSCAI
• Confirmed: Y
• Topic: TBD
• On-site phone: 978-501-2158

11:30 AM

• Interviewee: Andrew J. Boyle, M.D.
• Confirmed: Y
• Trial: The VentrAssist U.S. Pivotal Bridge to Cardiac Transplantation Trial
• On-site phone: 612-578-9149

12:00 PM

• Interviewee: Chris Cates
• Confirmed: Y
• Trial: Acute stroke intervention and neuro-rescue

1:00 PM

• Interviewee: Steven R. Bailey, M.D., FSCAI
• Confirmed: Y
• Topic: TBD
• On-site phone: 210-416-3175

4:00 PM

• Interviewee: Ted Feldman, MD, FSCAI,
• Confirmed: Y
• Topic: Evalve, SYNTAX, and PFO for stroke + migraine
• On-site phone:

4:30 PM

• Interviewee: Davy Cheng
• Confirmed (Y/N): Y
• Trial: Endovascular Versus Open Surgical Repair of Thoracic Aortic Disease: A Meta-regression Analysis
• Phone number: 519-859-0219

5:00 PM

• Interviewee: Christian Hamm
• Confirmed (Y/N): Y
• Trial: Prehospital Tirofiban in ST-Elevation Myocardial Infarction: One-Year Outcome of ON-TIME-2
• Phone number: + 49 172 69 36 243

Return to top

Monday March 30, 2009

Presentations will occur throughout the day on Monday. Dr. Gibson will not be available to interview between 12:00 and 2:00 PM, 4:30 to 5:30 PM, and 6:00 PM to 9:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:30 AM

• Interviewee: David Cohen
• Confirmed: Y
• Trial: Health Related Quality of Life and U.S. Based Economic Outcomes of PCI With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel and Left Main Coronary Artery Disease: 1-Year Results From the SYNTAX Trial
• On-site phone: 617-519-0310

9:00 AM

• Interviewee: Mark Creager
• Confirmed: Y
• Trial: Treatment of Intermittent Claudication With Hypoxia-Inducible Factor-1α
• On-site phone:

10:00 AM

• Interviewee: Robert Hendel
• Confirmed: Y
• Trial: Multicenter Assessment of the Utilization of SPECT Myocardial Perfusion Imaging Using the ACCF Appropriateness Criteria: The ACCF and United HealthCare SPECT Pilot Study
• On-site phone: 630-310-2162

10:30 AM

• Interviewee: Daniel Mark
• Confirmed: Y
• Trial: Quality of Life Outcomes With Surgical Ventricular Reconstruction in Symptomatic Heart Failure: Results From the STICH Trial
• On-site phone:

11:00 AM

• Interviewee: Germano DiSciascio
• Confirmed: Y
• Trial: Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention. Preliminary Results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Randomized Trial
• On-site phone: +39-335-6157260

11:30 AM

• Interviewee: Larry S Dean, M.D., FSCAI
• Topic: Washington State DES coverage decision OR Washington off-site surgery CON process
• Confirmed: Y
• On-site phone:

2:30 PM

• Interviewee: Mark Turco, MD, FSCAI
• Confirmed: Y
• Topic: Comparative Effectiveness Research
• On-site phone: 301-938-3485

3:15 PM

• Interviewee: Tobias Reichlin
• Confirmed: Y
• Topic: Incremental Value of Copeptin for Rapid Rule out of Acute Myocardial Infarction
• On-site phone: 0041 79 755 06 31

5:00 PM

Return to top

Tuesday March 31, 2009

Presentations will occur throughout the day on Tuesday. Dr. Gibson will not be available to interview between 1:30 and 3:30 PM. As a presenter you should go ahead and speak about your topic and present your slides during these times (listed in green).

8:00 AM

• Interviewee: Gregory J. Dehmer, M.D., FSCAI
• Confirmed: Y
• Topic: PCI and surgical backup
• On-site phone: 254-721-3657

9:00 AM

• Interviewee: L. Kristin Newby and Robert Giugliano
• Confirmed (Y/N): Y
• Trial: Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes (EARLY ACS)
• Phone number: 617-842-8320 (Dr. Giugliano), 919-612-3305 (Dr. Newby)

11:00 AM

• Interviewee: George Dangas, MD, PhD, FSCAI
• Confirmed: Y
• Topic: TBD
• On-site phone: 917-432-4286

11:30 AM

• Interviewees: Norm Linsky and Tim Elsner
• Confirmed: Y
• Topic: Collaboration Between SCAI and Mended Hearts / Mended Little Hearts
• On-site phones: 202-741-9848 and 214-360-6150

12:00 PM

• Interviewee: George Dangas
• Confirmed (Y/N): Y
• Trial: Predictors of Stent Thrombosis After Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-AMI Trial
• Phone number: 917-432-4286

4:30 PM

• Interviewee: Raimund Erbel
• Confirmed: Y
• Topic: Signs of Subclinical Coronary Atherosclerosis Measured as Coronary Artery Calcification Improve Risk Prediction of Hard Events Beyond Traditional Risk Factors in an Unselected General Population: The Heinz Nixdorf Recall Study Five-Year Outcome Data
• On-site phone: 49 173 283 7339

5:30 PM

Return to top